$Chimerix (CMRX.US)$
This is all I need to hold and/or buy more on dips
"..Turning to clinical outcomes. The survival of H3 K27-mutant glioma patients who received ONC201 in the frontline setting following radiotherapy, which I'll notice the same setting of the ACTION trial was reported as 21.7 months from diagnosis in contrast to 12 months for patients who did not receive ONC201. Favorable survival outcomes among ONC201 treated patients were consistently observed across a variety of sensitivity ...

$reAlpha Tech (AIRE.US)$ Is there still a chance for this stock to rise to over $19?

$FSL Trust (D8DU.SG)$ Not sure why it takes a loooong time to process purchase everytime. Couldn't get to purchase when it was 0.34cents

What's happening pre-mkt?? $Siyata Mobile (SYTA.US)$

$LumiraDx (LMDX.US)$ break out baby

$Jiutian Chemical (C8R.SG)$
Jiutian fell below 0.031 support. May continue falling.

$Matinas BioPharma (MTNB.US)$
It's reasonable for stock to surge.
Patient with Candida krusei Infection in Matinas BioPharma’s Oral MAT2203 Expanded Access Program Achieves Complete Clinical Resolution